» Articles » PMID: 11171087

Gene Dose Effect Reveals No Gs-coupled A2A Adenosine Receptor Reserve in Murine T-lymphocytes: Studies of Cells from A2A-receptor-gene-deficient Mice

Overview
Journal Biochem J
Specialty Biochemistry
Date 2001 Feb 15
PMID 11171087
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Agonist binding to extracellular A2A adenosine receptors (A2ARs) inhibits the activation of virtually all tested functions of T-cells and can induce apoptosis in thymocytes. The evaluation of levels of expression of these immunosuppressive receptors is expected to clarify whether the absence of spare A2ARs (no 'receptor reserve') might be one of the mechanisms of attenuation of the effects of extracellular adenosine on T-cells. A2A transcript is found in T-cells and functional receptors can be demonstrated, but the density of receptor on T-cells is too low to be detected by radioligand binding. Studies of direct radioligand binding to murine brain with the selective A2AR agonist [3H]CGS21680 (2-(4-[(2-carboxyethyl)-phenyl]ethylamino)-5'-N-ethylcarboxamidoadenosine) established that striata levels of A2AR are virtually absent from A2A knock-out mice. Mice that are heterozygous (A2AR+/-) for the A2AR express significantly decreased levels of A2AR. To test for the presence of spare receptors in T-cells we took advantage of this gene dose effect and examined whether the decrease in the number of receptors in thymocytes from A2AR+/- mice was proportionately reflected in a decrease in the functional cAMP response of T-cells to adenosine. cAMP accumulation and apoptosis induced by adenosine and by A2AR agonist are of a lower magnitude in T-cells from A2AR+/- heterozygous mice than in T-cells from A2AR+/+ littermate control mice. These results indicate that there is no A2AR reserve in murine T-cells. Strongly decreased adenosine-triggered cAMP increases were detected in thymocytes from A2AR-/- mice, suggesting that A2B adenosine receptors cannot fully compensate for the loss of A2ARs in murine T-cells. We conclude that the number of A2ARs is the limiting factor in determining the maximal cAMP response of T-lymphocytes to extracellular adenosine, thereby minimizing the immunosuppressive effects of extracellular adenosine.

Citing Articles

Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects.

Zhang H, Felthaus O, Eigenberger A, Klein S, Prantl L Cells. 2024; 13(18.

PMID: 39329710 PMC: 11429654. DOI: 10.3390/cells13181526.


Chromosomal instability as a driver of cancer progression.

Chen X, Agustinus A, Li J, DiBona M, Bakhoum S Nat Rev Genet. 2024; 26(1):31-46.

PMID: 39075192 DOI: 10.1038/s41576-024-00761-7.


Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors.

Dutta S, Ganguly A, Chatterjee K, Spada S, Mukherjee S Biology (Basel). 2023; 12(2).

PMID: 36829496 PMC: 9952779. DOI: 10.3390/biology12020218.


Istradefylline modulates purinergic enzymes and reduces malignancy-associated factors in B16F10 melanoma cells.

da Silva J, Rossato Viana A, Passos D, Krause L, Miron V, Schetinger M Purinergic Signal. 2022; 19(4):633-650.

PMID: 36522571 PMC: 10754812. DOI: 10.1007/s11302-022-09909-8.


Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity.

Piovesan D, Tan J, Becker A, Banuelos J, Narasappa N, DiRenzo D Mol Cancer Ther. 2022; 21(6):948-959.

PMID: 35405741 PMC: 9381133. DOI: 10.1158/1535-7163.MCT-21-0802.


References
1.
Koshiba M, Kojima H, Huang S, Apasov S, Sitkovsky M . Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells. J Biol Chem. 1997; 272(41):25881-9. DOI: 10.1074/jbc.272.41.25881. View

2.
Huang S, Apasov S, Koshiba M, Sitkovsky M . Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood. 1997; 90(4):1600-10. View

3.
Camps M, Guma A, Vinals F, Testar X, Palacin M, Zorzano A . Evidence for the lack of spare high-affinity insulin receptors in skeletal muscle. Biochem J. 1992; 285 ( Pt 3):993-9. PMC: 1132893. DOI: 10.1042/bj2850993. View

4.
Hashimoto N, Suzuki F, Tamai I, Nikaido H, Kuwajima M, Hayakawa J . Gene-dose effect on carnitine transport activity in embryonic fibroblasts of JVS mice as a model of human carnitine transporter deficiency. Biochem Pharmacol. 1998; 55(10):1729-32. DOI: 10.1016/s0006-2952(97)00670-9. View

5.
Schwinger R, Bohm M, Erdmann E . Evidence against spare or uncoupled beta-adrenoceptors in the human heart. Am Heart J. 1990; 119(4):899-904. DOI: 10.1016/s0002-8703(05)80329-1. View